REVOLUTION Medicines Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$126.4M
Industry:Biotech
Founded:2014
Lead Investor(s):Nextech Invest

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • REVOLUTION Medicines's estimated annual revenue is currently $18.6M per year.
  • REVOLUTION Medicines received $56.0M in venture funding in April 2018.
  • REVOLUTION Medicines's estimated revenue per employee is $155,000
  • REVOLUTION Medicines's total funding is $126.4M.

Employee Data

  • REVOLUTION Medicines has 120 Employees.
  • REVOLUTION Medicines grew their employee count by 20% last year.
  • REVOLUTION Medicines currently has 2 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
DiaCarta
$7M4510%N/A-N/A
Geron Corporati...
N/A205N/AN/A-N/A
Rigel Pharmaceu...
$46.8M3024%N/A-N/A
Althea Technolo...
$22.3M144N/AN/A-N/A
INOVA Diagnosti...
$44.3M286N/AN/A-N/A
10X Genomics
$101.2M65346%N/A-N/A
ProTrials Resea...
$33.3M2153%N/A-N/A
Advanced Cell D...
$28.7M1858%N/A-N/A
The J. Craig Ve...
$39.4M254N/AN/A-N/A
CellMax Life
$6.5M4214%N/A-N/A
Missing a competitor? Contribute!?
Submit

REVOLUTION Medicines discovers and develops new drugs that harness the therapeutic potential of frontier oncology targets on behalf of cancer patients. Our innovative product engine draws inspiration from nature and evolution, which offer insights into cancer targets, disease mechanisms and therapeutic approaches. We pay particular attention to natural products that are inherently rich with biological function as a result of natural selection and can inform and guide our discovery and development of small molecules that can modulate these targets.

keywords:Biotechnology,Healthcare,Pharmaceuticals

120

Number of Employees

$18.6M

Revenue (est)

2

Current Jobs

20%

Employee Growth %

$126.4M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

REVOLUTION Medicines News

09/07/2019 - REVOLUTION Medicines Closes $100 Million Financing to ...

REDWOOD CITY, Calif., July 9, 2019 /PRNewswire/ -- REVOLUTION Medicines, Inc., a clinical-stage leader in the discovery and development ...

09/08/2019 - Amgen's drug targeting 'undruggable' protein shines at lung ...

In June, Frontier Medicines launched with a $67 million Series A ... And in July, Revolution Medicines raised a $100 million equity round for its ...

09/09/2019 - Lilly launches new report highlighting challenges and ...

... highlighting challenges and opportunities of health care revolution ... its global leadership position at the forefront of medicines research and ...

REVOLUTION Medicines Funding

DateAmountRoundLead InvestorsReference
2015-02-05$45.0MAThird Rock Ventures, LLCArticle
2016-12-21$25.0MAThe Column GroupArticle
2018-04-25$56.0MBNextech InvestArticle

REVOLUTION Medicines Executive Hires

DateNameTitleReference
2017-03-21Stephen KelseyPres Research And DevelopmentArticle

REVOLUTION Medicines Acquisitions

DateCompany NameAmountNotesReference
2018-10-17Warp Drive Bio, LLCArticle